Literature DB >> 4401308

Quantitative analysis on isolated organs of the autonomic blocking properties of indoramin hydrochloride (Wy 21901).

B J Alps, M Hill, E S Johnson, A B Wilson.   

Abstract

1. Indoramin is a competitive alpha-adrenoceptor blocking agent on the guinea-pig isolated vas deferens and aortic strip; the pA(2) value on the aorta is 7.4.2. Indoramin is devoid of beta-adrenoceptor blocking activity on the guinea-pig isolated trachea (10(-4)M) and the Langendorff preparation of the rabbit heart (10(-6)M). It also has no adrenergic neurone blocking action on the Finkleman preparation of the rabbit small intestine (10(-5)M).3. On the Langendorff preparation of the rabbit isolated heart, indoramin (above 10(-6)M) has cardio-inhibitory properties similar to those of propranolol.4. On the guinea-pig isolated ileum (10(-5)M) and trachea (10(-6)M), indoramin is devoid of anticholinergic activity, but has a potent antihistamine action which satisfies the criteria for competitive antagonism; the pA(2) value for this antagonism on the ileum is 8.2.5. Indoramin antagonizes 5-hydroxytryptamine on the rat isolated fundus and ileum; the pA(2) value for the antagonism on the ileum is 6.0.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4401308      PMCID: PMC1665700          DOI: 10.1111/j.1476-5381.1972.tb07237.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

1.  THE SPIRALLY CUT TRACHEAL STRIP PREPARATION.

Authors:  J W CONSTANTINE
Journal:  J Pharm Pharmacol       Date:  1965-06       Impact factor: 3.765

2.  Quantitative studies of antagonists for 5-hydroxytryptamine.

Authors:  J H GADDUM; K A HAMEED; D E HATHWAY; F F STEPHENS
Journal:  Q J Exp Physiol Cogn Med Sci       Date:  1955-01

3.  Reactions of strips of rabbit aorta to epinephrine, isopropylarterenol, sodium nitrite and other drugs.

Authors:  R F FURCHGOTT; S BHADRAKOM
Journal:  J Pharmacol Exp Ther       Date:  1953-06       Impact factor: 4.030

4.  On the nature of inhibition in the intestine.

Authors:  B Finkleman
Journal:  J Physiol       Date:  1930-09-18       Impact factor: 5.182

5.  Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine.

Authors:  A T Birmingham; J Szolcsányi
Journal:  J Pharm Pharmacol       Date:  1965-07       Impact factor: 3.765

6.  Adrenergic mechanisms in the initiation of cardiac arrhythmias.

Authors:  H L Garvey
Journal:  Arch Int Pharmacodyn Ther       Date:  1969-12

7.  Evidence for adrenergic alpha receptor depressant activity in the heart.

Authors:  T N James; E S Bear; K F Lang; E W Green
Journal:  Am J Physiol       Date:  1968-12

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

10.  A sensitive method for the assay of 5-hydroxytryptamine.

Authors:  J R VANE
Journal:  Br J Pharmacol Chemother       Date:  1957-09
View more
  11 in total

1.  Double-blind trial of indoramin in digital artery disease.

Authors:  P Robson; V Pearce; A C Antcliff; M Hamilton
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

2.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

3.  Cardiovascular effects of indoramin in man--a dose ranging study.

Authors:  D P Nicholls; D W Harron; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

4.  Effect of indoramin on human sperm motility.

Authors:  R B Verma; S M Abrams; P Turner
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

5.  The effect of indoramin on peripheral blood flow.

Authors:  R B Royds; J D Lockhart
Journal:  Br J Clin Pharmacol       Date:  1974-02       Impact factor: 4.335

6.  Effect of indoramin on finger blood flow in vasospastic patients.

Authors:  D L Clement
Journal:  Eur J Clin Pharmacol       Date:  1978-12-18       Impact factor: 2.953

Review 7.  Indoramin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and related vascular, cardiovascular and airway diseases.

Authors:  B Holmes; E M Sorkin
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

8.  Differential blockade of alpha-adrenoceptors by indoramin.

Authors:  D P Nicholls; P C O'Connor; D W Harron; W J Leahey; R G Shanks
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

9.  Alpha 2-adrenoceptor antagonism and other pharmacological antagonist properties of some substituted benzoquinolizines and yohimbine in vitro.

Authors:  N Lattimer; R P McAdams; K F Rhodes; S Sharma; S J Turner; J F Waterfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

10.  Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.

Authors:  V Pierce; N B Shepperson; M H Todd; J F Waterfall
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.